•  
  •  
 

The Science Journal of the Lander College of Arts and Sciences

Authors

Joshua Sodden

Abstract

Osteoporosis is a bone disease that leads to frail bones, caused by osteoclasts destroying more bone than osteoblasts can create. It is more common among elderly people due to a lack of growth factors that promote osteoblasts. Estrogen plays a very important role in bone homeostasis of women; therefore post-menopausal women are most commonly affected because of their lack of estrogen production. Currently the FDA has approved eleven different drug treatments for osteoporosis. These treatments include anabolic treatments such as parathyroid hormone and anti-sclerostin, as well as catabolic treatments which include bisphosphonates, estrogen hormone, SERMs and anti-RANKL. This paper describes and analyzes each treatment to determine the best treatment option. It concludes that there may not be a definitive best treatment, rather drug characteristics and patient preferences must be taken into account.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.